Regulatory Surveillance Over Weight Loss Drug Supply Chain
New Delhi: In order to ensure ethical pharmaceutical practices in the supply chain of Weight Loss Drug (GLP-1), the Drugs Controller of India has intensified its regulatory surveillance against the drug’s unauthorized sale and promotion. With the recent introduction of multiple generic variants of GLP-1-based weight loss drugs in the Indian market, concerns have emerged […]
Read More